MRI Interventions to Report First Quarter 2013 Financial Results
MEMPHIS, Tenn., April 29, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its first quarter 2013 financial results on Thursday, May 9, 2013, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
| What: | MRI Interventions' first quarter 2013 financial results conference call |
| When: | Thursday, May 9, 2013, at 4:30 p.m. Eastern Time |
| Dial In Number: | 877-407-9034 (United States and Canada) |
| 201-493-6737 (International) | |
| Webcast: | A link to the live and replay webcast of the conference call can be found on MRI Interventions' website at https://ir.stockpr.com/mriinterventions/ir-calendar |
| Call Replay: | A playback of the call will be available through May 16, 2013 |
| Replay Number: | 877-660-6853 (United States and Canada) |
| 201-612-7415 (International) | |
| Conference ID #: 413671 |
About MRI Interventions, Inc.
Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint® system is designed to enable a wide range of minimally invasive procedures in the brain. MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, relating to the ClearPoint system. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. MRI Interventions is also working with Boston Scientific Corporation to incorporate its MRI-safety technologies into Boston Scientific's implantable leads for cardiac and neurological applications. For more information, please visit www.MRIinterventions.com.
CONTACT: MRI Interventions, Inc.
David Carlson, CFO, 901-522-9300
Source: MRI Interventions, Inc.
Released April 29, 2013